newsfilter
← Latest News
Business Wire·

Cortexyme Successfully Completes Acquisition of Novosteo

Cortexyme, Inc. (NASDAQ:CRTX), a clinical-stage biopharmaceutical company developing therapeutic approaches to improve the lives of patients diagnosed with degenerative diseases, today announced the completion of its acquisition of Novosteo, a privately